XML 89 R78.htm IDEA: XBRL DOCUMENT v3.5.0.2
SUBSEQUENT EVENTS (Details) - USD ($)
$ in Millions
3 Months Ended
Aug. 09, 2016
Jun. 30, 2016
Aug. 08, 2016
Subsequent Event      
Subsequent Event [Line Items]      
Lenders percentage of of principal held required to approve amendment 50.00%    
Pharming Group N.V., North American Commercialization Rights to Ruconest      
Subsequent Event [Line Items]      
Impairment loss   $ 199  
Pharming Group N.V., North American Commercialization Rights to Ruconest | Subsequent Event      
Subsequent Event [Line Items]      
Upfront purchase price     $ 125
Upfront fee     60
Sales based milestone payments receivable (up to)     $ 65